Impact of Antimigraine Compounds on Cognitive Processing: A Placebo‐Controlled Crossover Study

Abstract

Our data suggest that there may be a slight cognitive decline 2 hours after ingestion of ergotamine tartrate and, to an even lesser extent, zolmitriptan, but not after ingestion of sumatriptan or placebo. All changes recorded were very mild and unlikely to be clinically relevant.